Clinical trial
Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to…
NCT00245609 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00245609 |
|---|---|
| Title | Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial Of The Anxiolytic Efficacy Of Pregabalin And Alprazolam IR In Subjects With Anxiety Prior To Dental Procedure |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Dental Anxiety |
| Intervention type | Drug |
| Interventions | Pregabalin, Alprazolam, Placebo |
| Enrollment | 90 |
| Start date | Jan 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Oct 28, 2005 |
| Last update posted | Jan 22, 2021 |
| Countries | Germany, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: